NCT03948568View on ClinicalTrials.gov

Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

PHASE4CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

June 9, 2021

Study Completion Date

April 9, 2022

Conditions
Early-stage Breast Cancer
Interventions
COMBINATION_PRODUCT

Endocrine Therapy and Radiotherapy

Endocrine therapy and radiotherapy administered either concurrently or sequentially

Trial Locations (1)

K1H 8M2

Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER